News | May 16, 2025
Piramal Pharma reports Q4 FY25 consolidated net profit of Rs. 153.50 Cr
The company has posted net profit of Rs. 91.13 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 91.13 crores for the Financial Year ended March 31, 2025
EBITDA before special items decreases to €4.08 billion (7.4%)
_256_384.jpg)
The company reported 30.1% jump in Q4 FY25 PAT at Rs. 1,222 crore
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
Standalone profit from operations for Q4-2024 were Rs. 108 crore
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
Prithwish has close to 28 years of experience in a Commercial role
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
Poor oral health (periodontal disease) impacts nearly 51% of Indians
Subscribe To Our Newsletter & Stay Updated
